Open Access 04.06.2020 | COVID-19 | Letter
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial
Erschienen in: Trials | Ausgabe 1/2020